This is incorrect. See Bolognia p 706 “Lastly, the subset of patients with anti-RNA polymerase III antibodies is more likely to have rapidly progressive, diffuse skin disease, and renal involvement. This subset may also have an increased risk of an associated malignancy, most commonly breast cancer”